Adaptimmune Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.0k | 38k | 0.13 |
| 2025-06-30 | $43k | 179k | 0.24 |
| 2025-03-31 | $36k | 184k | 0.20 |
| 2024-12-31 | $99k | 184k | 0.54 |
| 2024-09-30 | $270k | 284k | 0.95 |